Abstract

IRRITABLE BOWEL SYNDROME: UNDERSTANDING SYMPTOMS AND MANAGEMENT-REVIEW ARTICLE OF UPDATED DATA FOR HEALTHCARE PROVIDERS

‏*Naifa Hail Alaida, ‏Zainab Ali AlQarni and Sultan Sulaiman Alharbi

ABSTRACT

Background: Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder affecting 5% to 20% of the global population. It is characterized by a range of symptoms, including abdominal pain, diarrhea, and constipation, significantly impacting patients' quality of life. Aim: This review aims to synthesize updated information regarding the symptoms, diagnosis, and management of IBS to better inform healthcare providers. Methods: A comprehensive literature review was conducted, focusing on the incidence, symptoms, diagnostic criteria (particularly the Rome III criteria), and treatment options for IBS. The review also examines the multifactorial pathogenesis of IBS, including genetic and psychological factors. Results: The review reveals that IBS can present with varying symptoms, with about one-third of patients experiencing diarrhea-predominant IBS (IBS-D) and one-third experiencing constipation-predominant IBS (IBS-C). Current diagnostic practices primarily rely on symptom assessment rather than biochemical or radiological tests. Management strategies include pharmacological treatments with limited long-term efficacy, alongside alternative therapies such as cognitive behavioral therapy, which show promise in alleviating symptoms. Conclusion: Effective management of IBS requires a multifaceted approach, recognizing the complexity of its symptoms and the interplay of various biological and psychological factors. Increased awareness and understanding among healthcare providers can lead to improved patient outcomes.

Keywords: Irritable bowel syndrome, diagnosis, treatment, gastrointestinal symptoms, quality of life.